Trials / Unknown
UnknownNCT05915520
Baduanjin Program Effect on Geriatric Functional Dyspepsia
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 65 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
functional dyspepsia is very common between geriatric population
Detailed description
Forty Egyptian geriatrics with functional dyspepsia, after randomization, will be divided to 2 groups; the first 20-geriatric group will receive 5-session per-week 40-minute baduinjuin for 8 weeks plus the daily dose of pantoprazole (40 mg orally administered tablet drug. in the other 20-geriatric group, the daily dose of drug will be administered only for 8 weeks .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | baduinjuin activities | in this 20-geriatric group will receive 5-session per-week 40-minute baduinjuin for 8 weeks plus the daily dose of pantoprazole (40 mg orally administered tablet drug) |
| OTHER | pantoprazole | in this 20-geriatric group will receive the daily dose of pantoprazole (40 mg orally administered tablet drug for 8 weeks . |
Timeline
- Start date
- 2023-07-20
- Primary completion
- 2024-01-30
- Completion
- 2024-01-30
- First posted
- 2023-06-23
- Last updated
- 2023-06-23
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05915520. Inclusion in this directory is not an endorsement.